Welcome to LookChem.com Sign In|Join Free
  • or
D-val-D-FDLA is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

199729-55-0

Post Buying Request

199729-55-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

199729-55-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 199729-55-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,9,7,2 and 9 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 199729-55:
(8*1)+(7*9)+(6*9)+(5*7)+(4*2)+(3*9)+(2*5)+(1*5)=210
210 % 10 = 0
So 199729-55-0 is a valid CAS Registry Number.

199729-55-0Downstream Products

199729-55-0Relevant academic research and scientific papers

Genomics-Driven Discovery of Chlorinated Cyclic Hexapeptides Ulleungmycins A and B from a Streptomyces Species

Son, Sangkeun,Hong, Young-Soo,Jang, Mina,Heo, Kyung Taek,Lee, Byeongsan,Jang, Jun-Pil,Kim, Jong-Won,Ryoo, In-Ja,Kim, Won-Gon,Ko, Sung-Kyun,Kim, Bo Yeon,Jang, Jae-Hyuk,Ahn, Jong Seog

, p. 3025 - 3031 (2017)

Analysis of the genome sequence of Streptomyces sp. KCB13F003 showed the presence of a cryptic gene cluster encoding flavin-dependent halogenase and nonribosomal peptide synthetase. Pleiotropic approaches using multiple culture media followed by LC-MS-guided isolation and spectroscopic analysis enabled the identification of two new chlorinated cyclic hexapeptides, ulleungmycins A and B (1 and 2). Their structures, including absolute configurations, were determined by 1D and 2D NMR techniques, advanced Marfey's analysis, and GITC derivatization. The new peptides, featuring unusual amino acids 5-chloro-l-tryptophan and d-homoleucine, exhibited moderate antibacterial activities against Gram-positive pathogenic bacteria including methicillin-resistant and quinolone-resistant Staphylococcus aureus.

Melicopteline A-E, Unusual Cyclopeptide Alkaloids with Antiviral Activity against Influenza A Virus from Melicope pteleifolia

Lee, Ba Wool,Quy Ha, Thi Kim,Park, Eun Jin,Cho, Hyo Moon,Ryu, Byeol,Doan, Thi Phuong,Lee, Hee Ju,Oh, Won Keun

, p. 1437 - 1447 (2021/01/13)

In the search for antiviral cyclopeptides against influenza A virus, five unprecedented Caryophyllaceae-type cyclopeptides (1-5) were isolated from the leaves of Melicope pteleifolia. Their chemical structures and absolute configurations were unambiguousl

Argicyclamides A-C Unveil Enzymatic Basis for Guanidine Bis-prenylation

Balloo, Nandani,Fujita, Kei,Matsuda, Kenichi,Okino, Tatsufumi,Phan, Chin-Soon,Wakimoto, Toshiyuki

supporting information, p. 10083 - 10087 (2021/07/26)

Guanidine prenylation is an outstanding modification in alkaloid and peptide biosynthesis, but its enzymatic basis has remained elusive. We report the isolation of argicyclamides, a new class of cyanobactins with unique mono- and bis-prenylations on guanidine moieties, from Microcystis aeruginosa NIES-88. The genetic basis of argicyclamide biosynthesis was established by the heterologous expression and in vitro characterization of biosynthetic enzymes including AgcF, a new guanidine prenyltransferase. This study provides important insight into the biosynthesis of prenylated guanidines and offers a new toolkit for peptide modification.

Anti-MRSA actinomycins D1-D4 from the marine sponge-associated Streptomyces sp. LHW52447

Jiao, Wei-Hua,Yuan, Wei,Li, Zhi-Yong,Li, Jing,Li, Lei,Sun, Jia-Bao,Gui, Yu-Han,Wang, Jie,Ye, Bo-Ping,Lin, Hou-Wen

, p. 5914 - 5919 (2018/08/29)

Actinomycins D1?D4 (1–4), four new D-type actinomycin analogues, were isolated from the fermentation broth of a strain of marine sponge-associated Streptomyces sp. LHW52447, together with actinomycin D (5). The structures of 1?4 were

Coculture of a Pathogenic Actinomycete and Animal Cells to Produce Nocarjamide, a Cyclic Nonapeptide with Wnt Signal-Activating Effect

Hara, Yasumasa,Arai, Midori A.,Toume, Kazufumi,Masu, Hyuma,Sato, Tomoyuki,Komatsu, Katsuko,Yaguchi, Takashi,Ishibashi, Masami

supporting information, p. 5831 - 5834 (2018/09/12)

A coculture method with a pathogenic actinomycete of the genus Nocardia and an animal cell line was designed to reconstruct and emulate the initial infection state, and a new cyclic nonapeptide, named nocarjamide (1), was obtained by coculture of Nocardia tenerifensis IFM 10554T and the mouse macrophage-like cell line J774.1 in a modified Czapek-Dox medium. Nocarjamide (1) exhibited Wnt signal-activating effects.

Octaminomycins A and B, cyclic octadepsipeptides active against Plasmodium falciparum

Jang, Jun-Pil,Nogawa, Toshihiko,Futamura, Yushi,Shimizu, Takeshi,Hashizume, Daisuke,Takahashi, Shunji,Jang, Jae-Hyuk,Ahn, Jong Seog,Osada, Hiroyuki

, p. 134 - 140 (2017/02/05)

Two new cyclic octadepsipeptides, octaminomycins A (1) and B (2), were isolated from a microbial metabolite fraction library of Streptomyces sp. RK85-270 based on Natural Products Plot screening. Their structures were elucidated on the basis of HRESIMS, 1D and 2D NMR spectroscopic data, and MS/MS experiments for sequence analysis. The absolute configurations of the constituent amino acid residues were determined by a combination of single-crystal X-ray diffraction and Marfey's methodology. Notably, octaminomycins A (1) and B (2) showed good in vitro antiplasmodial activity against chloroquine-sensitive as well as chloroquine-resistant strains with no cytotoxicity up to 30 μM. (Chemical Equation Presented).

Urumamide, a novel chymotrypsin inhibitor with a β-amino acid from a marine cyanobacterium Okeania sp.

Kanamori, Yuki,Iwasaki, Arihiro,Sumimoto, Shinpei,Suenaga, Kiyotake

supporting information, p. 4213 - 4216 (2016/08/25)

Urumamide, a novel cyclic depsipeptide that contains a β-amino acid, was isolated from a marine cyanobacterium Okeania sp. Its gross structure was determined by spectroscopic analyses, and the absolute configuration was established based on Marfey's analyses and chiral HPLC analyses of hydrolysis products. Biologically, urumamide inhibited the growth of human cancer cells. In addition, urumamide inhibited chymotrypsin.

Application of 3D NMR for Structure Determination of Peptide Natural Products

Zhang, Fan,Adnani, Navid,Vazquez-Rivera, Emmanuel,Braun, Doug R.,Tonelli, Marco,Andes, David R.,Bugni, Tim S.

, p. 8713 - 8719 (2015/09/15)

Despite the advances in NMR, structure determination is often slow and constitutes a bottleneck in natural products discovery. Removal of this bottleneck would greatly improve the throughput for antibiotic discovery as well as other therapeutic areas. Overall, faster structure methods for structure determination will serve the natural products community in a broad manner. This report describes the first application of 3D NMR for elucidation of two microbially produced peptide natural products with novel structures. The methods are cost-effective and greatly improve the confidence in a proposed structure.

Structure and biosynthesis of xenoamicins from entomopathogenic xenorhabdus

Zhou, Qiuqin,Grundmann, Florian,Kaiser, Marcel,Schiell, Matthias,Gaudriault, Sophie,Batzer, Andreas,Kurz, Michael,Bode, Helge B.

supporting information, p. 16772 - 16779 (2014/01/06)

During the search for novel natural products from entomopathogenic Xenorhabdus doucetiae DSM17909 and X. mauleonii DSM17908 novel peptides named xenoamicins were identified in addition to the already known antibiotics xenocoumacin and xenorhabdin. Xenoamicins are acylated tridecadepsipeptides consisting of mainly hydrophobic amino acids. The main derivative xenoamicin A (1) was isolated from X. mauleonii DSM17908, and its structure elucidated by detailed 1 D and 2 D NMR experiments. Detailed MS experiments, also in combination with labeling experiments, confirmed the determined structure and allowed structure elucidation of additional derivatives. Moreover, the xenoamicin biosynthesis gene cluster was identified and analyzed in X. doucetiae DSM17909, and its participation in xenoamicin biosynthesis was confirmed by mutagenesis. Advanced Marfey's analysis of 1 showed that the absolute configuration of the amino acids is in agreement with the predicted stereochemistry deduced from the nonribosomal peptide synthetase XabABCD. Biological testing revealed activity of 1 against Plasmodium falciparum and other neglected tropical diseases but no antibacterial activity.

Tumescenamide C, an antimicrobial cyclic lipodepsipeptide from Streptomyces sp.

Kishimoto, Shinji,Tsunematsu, Yuta,Nishimura, Shinichi,Hayashi, Yutaka,Hattori, Akira,Kakeya, Hideaki

experimental part, p. 5572 - 5578 (2012/09/08)

Tumescenamide C, a new cyclic lipodepsipeptide, was isolated from a culture broth of an actinomycete Streptomyces sp. KUSC-F05. Tumescenamide C was a congener of tumescenamides A and B, representing a sixteen-membered ring system, consisting of two proteinogenic and three non-proteinogenic amino acids, to which a methyl-branched fatty acid was attached. The planar structure was determined by spectroscopic analysis, while its absolute stereochemistry was determined by chemical degradation and asymmetric synthesis. Tumescenamide C exhibited antimicrobial activity with high selectivity against Streptomyces species.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 199729-55-0